Halazepam

Halazepam

Clinical data
Other names	9-chloro-6-phenyl-2-(2,2,2-trifluoroethyl)-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-3-one
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a684001
Pregnancy category	?
Routes of administration	Oral
ATC code	N05BA13 (WHO)
Legal status
Legal status	BR: Class B1 (Psychoactive drugs)[1] CA: Schedule IV DE: Prescription only (Anlage III for higher doses) US: Schedule IV
Pharmacokinetic data
Metabolism	Hepatic
Elimination half-life	14 hours (halazepam), 50–100 hours (metabolites).
Excretion	Renal
Identifiers
IUPAC name 7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one
CAS Number	23092-17-3 Y
PubChem CID	31640
IUPHAR/BPS	7195
DrugBank	DB00801 Y
ChemSpider	29343 Y
UNII	320YC168LF
KEGG	D00338 Y
ChEMBL	ChEMBL970 Y
CompTox Dashboard (EPA)	DTXSID5023118
ECHA InfoCard	100.041.281
Chemical and physical data
Formula	C17H12ClF3N2O
Molar mass	352.74 g·mol−1
3D model (JSmol)	Interactive image
SMILES FC(F)(CN1C(CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3)=O)F
InChI InChI=1S/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2 Y Key:WYCLKVQLVUQKNZ-UHFFFAOYSA-N Y
(verify)

Halazepam is a benzodiazepine derivative that was marketed under the brand names Paxipam in the United States,^[2] Alapryl in Spain,^[3] and Pacinone in Portugal.^[4]